Latest Accretion Pharmaceuticals stock price
Accretion Pharmaceuticals P/E Ratio
ACCPL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
12.62
Low Valuation
Low - May indicate good value opportunity
Current Valuation Metrics
P/E Ratio
12.62
Current Price
₹
EPS (TTM)
₹8.48
Exchange
None
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
53.71
Sector Median
31.12
Sector Rank
#11 of 131
Sector Percentile
8.4%
Key P/E Ratio Insights for Accretion Pharmaceuticals
- Stock appears undervalued with PE of 12.62, suggesting potential buying opportunity
- Trading at discount to sector average PE of 53.71
View the ACCPL equity price for detailed stock performance.
Related Pages for Accretion Pharmaceuticals
Additional stock information and data for ACCPL
Sector P/E Ratio Comparison
Comparing Accretion Pharmaceuticals with other companies in Healthcare sector
Sector Average
53.71
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |